ResMed (NYSE: RMD, ASX: RMD), a leading health technology company specializing in sleep, breathing, and at-home care, has announced a comprehensive brand evolution. This initiative aims to unify its brand portfolio, extend its reach to more people and healthcare providers globally, and reflect its growing engagement with consumers directly.
For 35 years, ResMed has been at the forefront of innovation in respiratory therapy, including CPAP therapy and digital health solutions. A significant brand update in 2014 marked its shift toward connectivity, introducing cloud-connected medical devices that transformed sleep apnea treatment. Now, ResMed is transforming into a unified health technology brand, catering to millions of consumers, healthcare professionals, and software users worldwide.
Globally, an estimated 2.3+ billion individuals grapple with sleep apnea, insomnia, COPD, or other respiratory issues. Furthermore, ResMed’s 2025 Global Sleep Survey underscores the widespread impact of poor sleep, with one-third of respondents reporting sleep difficulties, such as trouble falling asleep (34%) and staying asleep (29%).
Katrin Pucknat, ResMed’s Chief Marketing Officer, stated, “We are at a pivotal moment in health – sleep and breathing health are gaining the attention once reserved for diet and exercise, with consumers taking a more proactive role in their care. Our brand evolution is more than a new look – it’s a bold step forward in our strategy to make sleep and breathing health a mainstream priority in global healthcare.”
As part of this brand evolution, ResMed intends to consolidate its brands, products, and services under a single ResMed brand over the next couple of years, creating a more streamlined experience for both consumers and healthcare providers. This transformation incorporates a refreshed visual identity, a redesigned logo, and an updated brand voice, reinforcing ResMed’s position as a forward-thinking, people-centered health technology company.
The brand evolution aligns with ResMed’s mission to create health technologies that people love. It coincides with three significant market-facing initiatives designed to reshape perceptions of sleep therapy and boost awareness of sleep apnea treatment:
- The company’s first U.S. consumer campaign aimed to destigmatize CPAP therapy and promote sleep health as more accessible.
- A targeted primary care physician (PCP) education campaign commencing in the U.S. to help facilitate earlier diagnosis and intervention for sleep apnea.
- A sleep health awareness campaign in crucial markets in Asia Pacific and Europe focused on overcoming barriers to seeking treatment for sleep apnea.
Mick Farrell, ResMed’s Chairman & CEO, noted, “ResMed has evolved beyond its origins as a CPAP device and mask manufacturer. Our new brand reflects who we are today – a global leader in health technology, delivering solutions that help people rise to their full potential through better sleep and breathing, with care delivered in the home. With this evolution, we are reaffirming our commitment to empowering 500 million people worldwide to achieve their full health potential by 2030 and changing the delivery of healthcare.”
To find out more about ResMed’s brand evolution, please visit resmed.com/brand-evolution.
About ResMed
Resmed (NYSE: RMD, ASX: RMD) creates life-changing health technologies that people love. We’re relentlessly committed to pioneering innovative technology to empower millions of people in 140 countries to live happier, healthier lives. Our AI-powered digital health solutions, cloud-connected devices and intelligent software make home healthcare more personalized, accessible and effective. Ultimately, Resmed envisions a world where every person can achieve their full potential through better sleep and breathing, with care delivered in their own home. Learn more about how we’re redefining sleep health at Resmed.com and follow @Resmed.
Source: Resmed Inc. via GLOBE NEWSWIRE
